2026年08月07日 日本語

Dexcom Acquires Nutrisense to Bring AI-Powered Glucose Tracking to the Masses

Dexcom is doubling down on the non-diabetic market with the acquisition of Nutrisense, a startup focused on continuous glucose monitoring (CGM) for wellness. Alongside this merger, Dexcom announced that its over-the-counter CGM, Stelo, has received an FDA-cleared redesign featuring “pattern recognition, proactive AI coaching, and personalized summaries.”

The updates aim to combat the “data fatigue” often experienced by healthy users who find constant glucose tracking overwhelming. By integrating AI that translates raw biological data into actionable lifestyle advice, Dexcom hopes to make the technology more accessible and less stressful for general health enthusiasts.

This strategic move signals a shift in the wearable market, where medical-grade sensors are becoming lifestyle accessories. With Nutrisense’s expertise and Stelo’s new AI features, Dexcom is positioning itself to lead the burgeoning field of personalized metabolic health tracking.